PL2100520T3 - Poprawa integralności bariery jelitowej - Google Patents

Poprawa integralności bariery jelitowej

Info

Publication number: PL2100520T3
Authority: PL; Poland
Prior art keywords: improvement; barrier integrity; intestinal barrier; mammal; acid
Prior art date: 2004-06-22

Application number

PL09158304T

Other languages

English (en)

Inventor

Tol Eric Alexander Franciscus Van

Linette Eustachia Maria Willemsen

Marleen Antoinette Koetsier

Christopher Beermann

Bernd Stahl

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-22

Filing date

2004-06-22

Publication date

2014-01-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34957849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2100520(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-06-22 Application filed by Nutricia Nv filed Critical Nutricia Nv

2014-01-31 Publication of PL2100520T3 publication Critical patent/PL2100520T3/pl

Links

210000005027 intestinal barrier Anatomy 0.000 title 1
230000007358 intestinal barrier function Effects 0.000 title 1
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 4
241000124008 Mammalia Species 0.000 abstract 2
JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 2
235000021342 arachidonic acid Nutrition 0.000 abstract 2
229940114079 arachidonic acid Drugs 0.000 abstract 2
235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 2
229960005135 eicosapentaenoic acid Drugs 0.000 abstract 2
JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 2
DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
230000004888 barrier function Effects 0.000 abstract 1
235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
229920001542 oligosaccharide Polymers 0.000 abstract 1
150000002482 oligosaccharides Chemical class 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
- A23L29/04—Fatty acids or derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pediatric Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Pulmonology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Glass Compositions (AREA)
Medicines Containing Plant Substances (AREA)

PL09158304T 2004-06-22 2004-06-22 Poprawa integralności bariery jelitowej PL2100520T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP09158304.7A EP2100520B1 (en)	2004-06-22	2004-06-22	Improvement of intestinal barrier integrity
EP04748674A EP1672987B1 (en)	2004-06-22	2004-06-22	Improvement of intestinal barrier integrity
PCT/NL2004/000444 WO2005122790A1 (en)	2004-06-22	2004-06-22	Improvement of intestinal barrier integrity
EP07108969A EP1815755B1 (en)	2004-06-22	2004-06-22	Improvement of intestinal barrier integrity

Publications (1)

Publication Number	Publication Date
PL2100520T3 true PL2100520T3 (pl)	2014-01-31

Family

ID=34957849

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PL07108969T PL1815755T3 (pl)	2004-06-22	2004-06-22	Polepszanie integralności bariery jelitowej
PL09158304T PL2100520T3 (pl)	2004-06-22	2004-06-22	Poprawa integralności bariery jelitowej
PL04748674T PL1672987T3 (pl)	2004-06-22	2004-06-22	Poprawa integralności bariery jelitowej

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL07108969T PL1815755T3 (pl)	2004-06-22	2004-06-22	Polepszanie integralności bariery jelitowej

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL04748674T PL1672987T3 (pl)	2004-06-22	2004-06-22	Poprawa integralności bariery jelitowej

Country Status (20)

Country	Link
US (4)	US8252769B2 (pl)
EP (3)	EP1815755B1 (pl)
JP (1)	JP4903695B2 (pl)
CN (1)	CN100589712C (pl)
AT (2)	ATE429155T1 (pl)
AU (1)	AU2004320743B2 (pl)
BR (1)	BRPI0418921A (pl)
CA (1)	CA2570205C (pl)
CY (1)	CY1109224T1 (pl)
DE (2)	DE602004020813D1 (pl)
DK (3)	DK1672987T3 (pl)
ES (3)	ES2285484T3 (pl)
NZ (1)	NZ552166A (pl)
PL (3)	PL1815755T3 (pl)
PT (3)	PT1815755E (pl)
RU (1)	RU2402240C2 (pl)
SI (1)	SI1815755T1 (pl)
UA (1)	UA81875C2 (pl)
WO (1)	WO2005122790A1 (pl)
ZA (1)	ZA200700138B (pl)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19836339B4 (de) *	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung
EP1597978A1 (en)	2004-05-17	2005-11-23	Nutricia N.V.	Synergism of GOS and polyfructose
US8252769B2 (en) *	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
EP1723951A1 (en) †	2005-04-21	2006-11-22	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
EP1721611A1 (en) *	2005-04-21	2006-11-15	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
SI1758469T2 (sl) *	2004-06-22	2013-12-31	N.V.Nutricia	IzboljĹˇanje integritete bariere pri HIV pacientih z uporabo maĹˇÄŤobnih kislin
CA2537452C (en) *	2005-03-09	2013-12-24	Abbott Laboratories	Concentrated human milk fortifier liquid
EP1714660A1 (en) *	2005-04-21	2006-10-25	N.V. Nutricia	Uronic acid and probiotics
ATE471665T1 (de) *	2005-04-21	2010-07-15	Nutricia Nv	Nahrungsergänzungsmittel für hiv-patienten
EP1776877A1 (en)	2005-10-21	2007-04-25	N.V. Nutricia	Method for stimulating the intestinal flora
WO2007058523A1 (en) *	2005-11-17	2007-05-24	N.V. Nutricia	Composition with docosapentaenoic acid
PL1800675T4 (pl)	2005-12-23	2012-02-29	Nutricia Nv	Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
JP4771882B2 (ja) *	2006-07-21	2011-09-14	味の素ゼネラルフーヅ株式会社	糖尿病または糖尿病性合併症の治療、予防、または改善作用を有する組成物およびこれを含有する飲料
US8691213B2 (en) *	2006-08-04	2014-04-08	SHS International	Protein free formula
EP1969952A1 (en) *	2007-03-07	2008-09-17	Friesland Brands B.V.	Allergen-free or dairy free LCPUFA powdered compositions and the use thereof in food products and especially infant formulas
WO2008153377A1 (en) *	2007-06-15	2008-12-18	N.V. Nutricia	Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
CN101888793B (zh) *	2007-09-17	2015-01-14	荷兰纽迪希亚公司	具有高能含量的营养配方
WO2009096772A1 (en) *	2008-02-01	2009-08-06	N.V. Nutricia	Composition for stimulating natural killer cell activity
EP2130440A1 (en) *	2008-06-06	2009-12-09	N.V. Nutricia	Inhibiting E. sakazakii growth
EP2285387B1 (en)	2008-06-13	2015-10-14	N.V. Nutricia	Nutrition for prevention of infections
MY159212A (en)	2008-09-02	2016-12-30	Nutricia Nv	Nutritional compositions with coated lipid globules
WO2010068086A1 (en)	2008-12-11	2010-06-17	N.V. Nutricia	Nutritional compositions with large lipid globule size
JP5738180B2 (ja) *	2009-03-26	2015-06-17	味の素ゼネラルフーヅ株式会社	生活習慣病を予防または治療するための医薬組成物およびそれに役立つ食品
WO2010109626A1 (ja)	2009-03-26	2010-09-30	味の素ゼネラルフーヅ株式会社	生活習慣病を予防または治療するための医薬組成物およびそれに役立つ食品
JP6006117B2 (ja) *	2009-11-12	2016-10-12	ネステクソシエテアノニム	腸内微生物叢バランス及び健康を促進するための栄養組成物
WO2011115476A1 (en) *	2010-03-17	2011-09-22	N.V. Nutricia	Infant nutrition for improving fatty acid composition of brain membranes later in life
CN103025178B (zh) *	2010-04-26	2015-02-11	雀巢产品技术援助有限公司	用于从胃肠外营养转换至肠内营养的营养组合物和方法
ES2548629T3 (es) *	2010-08-24	2015-10-19	Abbott Laboratories	Productos nutritivos que tienen propiedades organolépticas mejoradas
NZ610471A (en)	2010-11-02	2014-12-24	Abbott Lab	Stable concentrated liquid human milk fortifier
CN107019701B (zh)	2010-12-31	2020-07-28	雅培制药有限公司	使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
ES2804258T3 (es)	2010-12-31	2021-02-05	Abbott Lab	Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
WO2012177118A1 (en)	2011-06-22	2012-12-27	N.V. Nutricia	Method for reducing the occurrence of infection in young children
EP2734210B1 (en)	2011-07-22	2017-11-22	Abbott Laboratories	Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CA2846603A1 (en)	2011-08-29	2013-03-07	Abbott Laboratories	Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN103889239A (zh)	2011-10-18	2014-06-25	雀巢产品技术援助有限公司	用于促进肠血管生成和营养吸收和经肠喂养耐受性和/或预防和/或治疗肠炎、和/或肠损伤和手术后恢复的组合物
WO2013187755A1 (en)	2012-06-14	2013-12-19	N.V. Nutricia	Fermented infant formula with non digestible oligosaccharides
EP2928325A1 (en)	2012-12-10	2015-10-14	N.V. Nutricia	Nutritional composition with non digestible oligosaccharides
US9352020B2 (en) *	2013-03-15	2016-05-31	Mead Johnson Nutrition Company	Reducing proinflammatory response
BR112016009351B1 (pt)	2013-11-01	2020-12-22	N.V. Nutricia	Uso de lipídio para a preparação de uma composição nutricional e fórmula para recémnascidos
WO2015065194A1 (en)	2013-11-04	2015-05-07	N.V. Nutricia	Fermented formula with non digestible oligosaccharides
US9815473B2 (en)	2014-01-30	2017-11-14	Ford Global Technologies, Llc	Manual transmission clutch control using driveline measurements
EP3248003B1 (en) *	2015-01-23	2023-04-19	Société des Produits Nestlé S.A.	Method for determining the distinctive nutritional requirements of a patient
PL3574771T3 (pl)	2015-10-15	2023-03-13	N.V. Nutricia	Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu
CN105231461A (zh) *	2015-10-30	2016-01-13	中营康园（北京）科技有限公司	一种提高机体免疫力的营养组合物及其应用
MY196605A (en)	2016-12-09	2023-04-20	Nutricia Nv	Nutritional Composition for Improving Cell Membranes
JP7136807B2 (ja)	2017-04-17	2022-09-13	ザ・ユニバーシティ・オブ・シカゴ	ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
BR112019023772A2 (pt)	2017-05-12	2020-06-09	Evonik Operations Gmbh	método para detectar doenças induzidas por c. perfringens em animais e kit de diagnóstico
CN107198250B (zh) *	2017-05-23	2019-03-12	北京瑞千景科技发展有限公司	改善肠道微生态预防慢性病组合物和均衡营养食品及应用
US20210011027A1 (en) *	2018-03-02	2021-01-14	Evonik Operations Gmbh	In vitro method for detecting intestinal barrier failure in animals by determining ovotransferrin
MX2021006917A (es)	2018-12-14	2021-07-07	Evonik Operations Gmbh	Procedimiento in vitro para la deteccion de disbiosis intestinal aviar.
CN109527123A (zh) *	2018-12-14	2019-03-29	大连大学	一种对慢性肠炎具有改善作用的调和油
EP3969009B1 (en)	2019-05-15	2025-08-20	N.V. Nutricia	Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
US20220110985A1 (en)	2019-06-04	2022-04-14	N.V. Nutricia	Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
BR112021007254A2 (pt)	2019-06-04	2021-08-10	N.V. Nutricia	composição nutricional para lactentes ou crianças de primeira infância
PL437793A1 (pl) *	2021-05-07	2022-11-14	Uniwersytet Medyczny w Łodzi	Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)
GB2608587B (en) *	2021-06-25	2025-01-01	Mjn Us Holdings Llc	Use of extensively hydrolysed protein
US20240277739A1 (en) *	2021-07-01	2024-08-22	N.V. Nutricia	Nutritonal compositions for gut barrier function
WO2025233459A1 (en)	2024-05-08	2025-11-13	N.V. Nutricia	Nutritional composition for preventing intestinal barrier disruption

Family Cites Families (132)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2981629A (en)	1960-04-05	1961-04-25	Lewis F Ginnette	Process of dehydrating foams
DE2033677A1 (de)	1970-07-07	1972-02-17	Deutsche Laevosan Gesellschaft C F Boehringer & Sohne GmbH & Co KG, Suddeutsche Zucker AG, 6800 Mannheim	Arzneimittel
US4237118A (en)	1972-03-06	1980-12-02	Howard Alan N	Dietary supplement and dietary methods employing said supplement for the treatment of obesity
JPS5645951B2 (pl)	1973-05-21	1981-10-29
JPS5263224A (en)	1975-11-20	1977-05-25	Asahi Chem Ind Co Ltd	Resin compositions for coating powder with low-temperature curing prop erty
JPS5342340A (en)	1976-09-29	1978-04-17	Shin Kobe Electric Machinery	Method of producing battery plate
DE2844861A1 (de)	1978-10-14	1980-04-30	Kerstein Pharma Hameln Gmbh	Diaetetisches lebensmittel zur oralen oder kuenstlichen ernaehrung und verfahren zu seiner herstellung
FR2490496A1 (fr)	1980-09-19	1982-03-26	Roussel Uclaf	Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4438147A (en)	1982-06-25	1984-03-20	Societe D'assistance Technique Pour Produits Nestle S.A.	Foaming creamer and method of making same
CA1324529C (en)	1987-09-15	1993-11-23	Tatsuhiko Kan	Liquid food comprising polydextrose and oligosaccharides
DE3734962C1 (de)	1987-10-15	1989-01-05	Luitpold Werk Chem Pharm	Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC
IE61565B1 (en)	1988-08-24	1994-11-16	Akzo Nv	Heparin fragments and fractions with anti-HIV action
JP2782443B2 (ja)	1988-12-26	1998-07-30	將純吉原	抗エイズウィルス剤
DE3901048A1 (de)	1989-01-14	1990-07-19	Chimicasa Gmbh	Antikachectikum
JP2779963B2 (ja)	1989-02-09	1998-07-23	株式会社林原生物化学研究所	ビフィズス菌増殖促進剤
JPH02286058A (ja)	1989-04-28	1990-11-26	Nippon Synthetic Chem Ind Co Ltd:The	整腸剤
ES2033193B1 (es) *	1990-10-30	1994-01-16	Ganadera Union Ind Agro	Mezcla grasa para nutricion infantil y de adultos.
ES2157898T3 (es)	1991-01-24	2001-09-01	Martek Corp	Aceites microbianos y usos de los mismos.
FR2673812B1 (fr)	1991-03-13	1994-04-01	Roussel Uclaf	Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
GB9109125D0 (en)	1991-04-27	1991-06-12	Cerestar Holding Bv	Sweetening composition
IT1248060B (it)	1991-06-14	1995-01-05	Italfarmaco Spa	Eparine acilate come inibitori della replicazione di retrovirus
GB9116054D0 (en)	1991-07-24	1991-09-11	Efamol Holdings	Preparation of fatty acid medicaments
US5629023A (en)	1991-12-31	1997-05-13	Bland; Jeffrey S.	Medical food composition for metabolic detoxification
KR100256150B1 (ko)	1992-04-10	2000-07-01	오쓰까 아끼히꼬	장내 부패산물 생성을 억제시키는 음료 조성물
CA2089607C (en)	1992-11-05	1997-11-04	Ranjit K. Chandra	Nutritional supplement for the elderly
US5372852A (en) *	1992-11-25	1994-12-13	Tektronix, Inc.	Indirect printing process for applying selective phase change ink compositions to substrates
US5502041A (en)	1992-12-11	1996-03-26	The Center For Innovative Technology	Potent inhibitor of HIV reverse transcriptase
GB9304746D0 (en)	1993-03-09	1993-04-28	Scotia Holdings Plc	Treatment of viral infections
US5472952A (en)	1993-03-18	1995-12-05	Bristol-Myers Squibb Company	Partially hydrolyzed pectin in nutritional compositions
US5405637A (en)	1993-06-30	1995-04-11	Bristol-Myers Squibb Company	Milk protein partial hydrolysate and infant formula containing same
GB9318611D0 (en)	1993-09-08	1993-10-27	Sandoz Nutrition Ltd	Improvements in or relating to organic compounds
JP3310738B2 (ja)	1993-11-10	2002-08-05	株式会社ロッテ	低カロリーチョコレート
DE4404877C1 (de)	1994-02-17	1995-03-02	Ksk Industrielackierungen Gmbh	Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung
US5952314A (en)	1994-04-01	1999-09-14	Demichele; Stephen Joseph	Nutritional product for a person having ulcerative colitis
MX9605144A (es)	1994-04-01	1997-12-31	Abbott Lab	Producto nutritivo para el tratamiento de la colitis ulcerativa y uso del mismo.
US5444054A (en) *	1994-04-01	1995-08-22	Abbott Labatories	Method of treating ulcerative colitis
EP0692252B1 (en)	1994-06-14	2001-04-04	"Raffinerie Tirlemontoise", société anonyme:	Use of a composition containing inulin or oligofructose in cancer treatment
JP3419897B2 (ja) *	1994-07-22	2003-06-23	明治乳業株式会社	低アレルギー性調製乳
NL9401644A (nl)	1994-10-06	1996-05-01	Friesland Brands Bv	Voedingsmiddel voor zwangere en lacterende vrouwen
US5531988A (en)	1994-10-28	1996-07-02	Metagenics, Inc.	Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5531989A (en)	1994-10-28	1996-07-02	Metagenics, Inc.	Immunoglobulin and fiber-containing composition for human gastrointestinal health
EP0711503A3 (en)	1994-11-14	1997-11-26	Scotia Holdings Plc	Milk fortified with GLA and/or DGLA
JPH08151328A (ja)	1994-11-28	1996-06-11	Fuji Ratetsukusu Kk	エイズ感染防止潤滑剤
US5733579A (en)	1995-04-05	1998-03-31	Abbott Laboratories	Oral rehydration solution containing indigestible oligosaccharides
US20020016289A1 (en)	1995-06-01	2002-02-07	Orla M. Conneely	Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
US6099871A (en)	1995-06-01	2000-08-08	Bristol-Myers Squibb Company	Anti-regurgitation infant formula
US5827526A (en)	1995-07-11	1998-10-27	Abbott Laboratories	Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
EP0756828B2 (en)	1995-08-04	2010-09-22	N.V. Nutricia	Nutritional composition containing fibres
JPH0965855A (ja)	1995-08-28	1997-03-11	Otsuka Shokuhin Kk	低カロリー整腸食品素材
MY115050A (en)	1995-10-16	2003-03-31	Mead Johnson Nutrition Co	Diabetic nutritional product having controlled absorption of carbohydrate
AUPN881396A0 (en)	1996-03-20	1996-04-18	Arnott's Biscuits Limited	Enhancement of microbial colonization of the gastrointestinal tract
CA2205773A1 (en)	1996-06-21	1997-12-21	Kraft Foods, Inc.	Creamy, thick, hot beverage foam
EP0821885B2 (en)	1996-07-31	2006-06-07	"Raffinerie Tirlemontoise", société anonyme:	Fructan- and/or polydextrose-containing dairy powders, process for preparing same and their use
FR2752381B1 (fr) *	1996-08-13	1998-11-06	Pierre Moreau	Biotechnologie aviaire, micro nutriments biodisponibles. prevention et traitement de la physiopathologie specifique des maladies de degenerescence et du vieillissement
JP3792309B2 (ja)	1996-08-30	2006-07-05	サントリー株式会社	不飽和脂肪酸含有油脂の製造方法
GB9619660D0 (en)	1996-09-20	1996-11-06	Scient Hospital Suppl Int Ltd	Prevention of gastrointestinal damage
JPH10108647A (ja)	1996-10-08	1998-04-28	Meiji Seika Kaisha Ltd	胃切除術後患者用ミネラル補給材
AU5104198A (en)	1996-11-05	1998-05-29	Wisconsin Alumni Research Foundation	Use of conjugated linoleic acid to enhance natural killer lymphocyte function
JP4008974B2 (ja)	1996-12-12	2007-11-14	森永乳業株式会社	ビフィズス菌増殖促進組成物及びその用途
AUPO430496A0 (en)	1996-12-19	1997-01-23	Arnott's Biscuits Limited	Prebiotics and probiotics
DE19701382A1 (de)	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
HUP0300236A3 (en) *	1997-02-21	2003-09-29	Univ Tennessee Res Corp Knoxvi	Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis and process for their preparation
US5840361A (en)	1997-04-09	1998-11-24	Beech-Nut Nutrition Corporation	Fructan-containing baby food compositions and methods therefor
IL132148A0 (en)	1997-04-11	2001-03-19	Calgene Llc	Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
NL1005809C2 (nl)	1997-04-14	1998-10-19	Dsm Nv	Poederverfbindmiddelsamenstelling.
US5846569A (en)	1997-06-20	1998-12-08	Creative Labs, Inc.	Colostrum supplement
US6051260A (en) *	1998-04-07	2000-04-18	Healthcomm International, Inc.	Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
GB9808579D0 (en)	1998-04-22	1998-06-24	Novartis Nutrition Ag	Improvements in or relating to organic compounds
EP0958825A1 (en)	1998-05-18	1999-11-24	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer
FR2781673B1 (fr)	1998-07-28	2001-09-28	Univ Picardie	Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de)	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung
US6231889B1 (en)	1998-09-21	2001-05-15	Chronorx, Llc	Unit dosage forms for the treatment of herpes simplex
US6794495B1 (en)	1998-10-19	2004-09-21	New Nordic Danmark Aps	Composition comprising extensin and, optionally, pectic polysaccharides
DE69920970T2 (de)	1999-01-28	2006-03-09	Société des Produits Nestlé S.A.	Aromatisiertes lösliches aufhellerpulver
EP1074181A1 (en)	1999-08-03	2001-02-07	Societe Des Produits Nestle S.A.	Foaming creamer ingredient and powders containing it
DE19940011B4 (de)	1999-08-24	2009-04-02	Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte	Alginataufbereitung und deren Verwendung
US6737089B2 (en)	1999-08-27	2004-05-18	Morinda, Inc.	Morinda citrifolia (Noni) enhanced animal food product
EP1062873A1 (en)	1999-12-13	2000-12-27	N.V. Nutricia	Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
DE10006989A1 (de)	2000-02-16	2001-08-23	Nutricia Nv	Antiadhäsive Kohlenhydratmischung
US6846501B2 (en)	2000-04-12	2005-01-25	Mid-America Commercialization Corporation	Traditional snacks having balanced nutritional profiles
US6495599B2 (en) *	2000-04-13	2002-12-17	Abbott Laboratories	Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
EP1155627A1 (en)	2000-05-18	2001-11-21	Belovo Eggs & Egg Products	Eggs with balanced lipid composition
DE10027050A1 (de)	2000-06-02	2001-12-13	Karim Balan	Alginathaltige Zusammensetzung und deren Verwendung
US6426110B1 (en)	2000-08-11	2002-07-30	Global Health Sciences, Inc.	Low-carbohydrate high-protein creamer powder
US6592863B2 (en) *	2000-08-22	2003-07-15	Nestec S.A.	Nutritional composition
EP1321527A4 (en)	2000-08-30	2004-08-11	Amano Enzyme Inc	METHOD FOR INCREASING THE YIELD OF ALPHA-GALACTOSYL-CONTAINING OLIGOSACCHARIDES AND ANTI-CANDIDA COMPOSITIONS
CN1111541C (zh)	2000-09-15	2003-06-18	青岛海洋大学	一种聚甘露糖醛酸硫酸盐
US20050238655A1 (en)	2004-01-06	2005-10-27	Paul Stamets	Antiviral activity from medicinal mushrooms
US20020119928A1 (en)	2000-10-27	2002-08-29	Mcanalley Bill H.	Dietary supplement compositions
EP1208792A1 (de) *	2000-11-17	2002-05-29	Haag-Streit Ag	Vorrichtung und Verfahren zur Untersuchung und/oder Behandlung eines Auges
DE10057976B4 (de)	2000-11-22	2005-02-03	Südzucker AG Mannheim/Ochsenfurt	Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6511696B2 (en)	2000-12-13	2003-01-28	Novartis Nutrition Ag	Infant formula with free amino acids and nucleotides
FI109602B (fi) *	2001-01-25	2002-09-13	Valio Oy	Probioottiyhdistelmä
EP1355544A2 (en)	2001-01-30	2003-10-29	Unilever N.V.	Food product comprising protein coated gas microbubbles
EP1228694A1 (en)	2001-02-02	2002-08-07	Societe Des Produits Nestle S.A.	Aromatizing agent
US20030165604A1 (en)	2001-02-15	2003-09-04	Kazufumi Tsubaki	Products containing $g(b)-glucan
EP1243273A1 (en)	2001-03-22	2002-09-25	Societe Des Produits Nestle S.A.	Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
JP3814494B2 (ja) *	2001-04-27	2006-08-30	松下電器産業株式会社	色管理装置及び色管理システム
DE10136260B4 (de)	2001-07-25	2004-07-08	Südzucker AG Mannheim/Ochsenfurt	Inulin in Geliermittelzusammensetzungen
NL1018832C2 (nl)	2001-08-27	2003-03-03	Friesland Brands Bv	Melkvervangend voedingsmiddel omvattend johannesbroodpitmeel.
JP2003146887A (ja)	2001-11-07	2003-05-21	Gotoo Corporation:Kk	Ｎｋ細胞活性化作用を有する製剤および飲食品
AU2003245252A1 (en)	2002-04-30	2003-11-17	Fmc Corporation	Carrageenan based antimicrobial compositions
US6623954B1 (en)	2002-05-28	2003-09-23	Neose Technologies, Inc.	Process for removal of phosphorous from a dairy stream
CN100469361C (zh)	2002-06-19	2009-03-18	纽迪希亚公司	治疗或预防哺乳动物遭受代谢作用压力时的分解代谢或刺激性合成代谢的方法及组合物
EP1374878A1 (en)	2002-06-20	2004-01-02	N.V. Nutricia	Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
US20060110516A1 (en)	2002-08-30	2006-05-25	Holtus Maria F	Foaming ingredient and products containing the ingredient
US20040087490A1 (en)	2002-09-20	2004-05-06	Troup John P.	Nutritional compositions
US20040122105A1 (en)	2002-09-20	2004-06-24	Griscom Bettle	Transdermal compositions
US6974841B1 (en)	2002-09-27	2005-12-13	Rapisarda Family Irrevocable Trust	Pet anti-aging wellness supplement
GB0229015D0 (en)	2002-12-12	2003-01-15	Novartis Nutrition Ag	New Compound
US20040219188A1 (en) *	2003-05-02	2004-11-04	Comer Gail M.	Composition and methods for nutritional management of patients with hepatic disease
CN1863463B (zh)	2003-06-23	2011-05-04	雀巢技术公司	用于促进肠道屏障成熟的营养组合物
NZ544642A (en)	2003-06-23	2009-01-31	Nestec Sa	Infant or follow-on formula
EP1491570A1 (en)	2003-06-25	2004-12-29	DSM IP Assets B.V.	Powder coating composition for low temperature cure
AU2003904192A0 (en)	2003-08-11	2003-08-21	Adelaide Research and Innovaiton Pty Ltd	Method for inhibiting bacterial colonisation
JP4740866B2 (ja)	2003-10-24	2011-08-03	ナムローゼフェンノートシャップニュートリシア	乳児向けシンバイオティック組成物
ES2781848T3 (es)	2003-10-24	2020-09-08	Nutricia Nv	Oligosacáridos inmunomoduladores
FR2866203B1 (fr)	2004-02-13	2006-12-08	Roquette Freres	Procede de fabrication d'un produit de cuisson a base de gluten
EP1597978A1 (en)	2004-05-17	2005-11-23	Nutricia N.V.	Synergism of GOS and polyfructose
US8252769B2 (en)	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
EP1721611A1 (en)	2005-04-21	2006-11-15	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
EP1723951A1 (en)	2005-04-21	2006-11-22	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
SI1758469T2 (sl)	2004-06-22	2013-12-31	N.V.Nutricia	IzboljĹˇanje integritete bariere pri HIV pacientih z uporabo maĹˇÄŤobnih kislin
CN101014717A (zh)	2004-07-07	2007-08-08	综合医院公司	Atⅲ在全血及血浆中的直接激活
WO2006007676A1 (en)	2004-07-21	2006-01-26	Amazônia Fitomedicamentos Ltda.	Combination of active fractions from the plants euphorbia tirucalli l and ficos carica l. and method of treating cancer and aids
JP4653465B2 (ja)	2004-10-25	2011-03-16	泰信小林	ナチュラルキラー細胞の増殖促進方法およびそれに用いる培養組成物
ATE471665T1 (de)	2005-04-21	2010-07-15	Nutricia Nv	Nahrungsergänzungsmittel für hiv-patienten
EP1916908A1 (en)	2005-07-27	2008-05-07	Cantabria Group LCC	Phosphorylated glucomannane polysaccharides containing 1-6 and 1-2 linkages increase weight gain in poultry
ES2323551T3 (es)	2005-07-29	2009-07-20	Alcon Refractivehorizons, Inc.	Sistema de posicionamiento lateral de dispositivo oftalmico y procedimientos relacionados.
US20070231449A1 (en)	2006-03-30	2007-10-04	Nutracea	Non-starchy rice bran polysaccharides
WO2009096772A1 (en)	2008-02-01	2009-08-06	N.V. Nutricia	Composition for stimulating natural killer cell activity
US9281963B2 (en) *	2008-12-23	2016-03-08	Persistent Systems Limited	Method and system for email search

2004
- 2004-06-06 US US11/571,122 patent/US8252769B2/en active Active
- 2004-06-22 DK DK04748674T patent/DK1672987T3/da active
- 2004-06-22 EP EP07108969A patent/EP1815755B1/en not_active Revoked
- 2004-06-22 DK DK07108969T patent/DK1815755T3/da active
- 2004-06-22 PT PT07108969T patent/PT1815755E/pt unknown
- 2004-06-22 AT AT07108969T patent/ATE429155T1/de active
- 2004-06-22 PL PL07108969T patent/PL1815755T3/pl unknown
- 2004-06-22 DE DE602004020813T patent/DE602004020813D1/de not_active Expired - Lifetime
- 2004-06-22 BR BRPI0418921-3A patent/BRPI0418921A/pt not_active Application Discontinuation
- 2004-06-22 AU AU2004320743A patent/AU2004320743B2/en not_active Expired
- 2004-06-22 PL PL09158304T patent/PL2100520T3/pl unknown
- 2004-06-22 JP JP2007517980A patent/JP4903695B2/ja not_active Expired - Lifetime
- 2004-06-22 PT PT04748674T patent/PT1672987E/pt unknown
- 2004-06-22 CA CA2570205A patent/CA2570205C/en not_active Expired - Lifetime
- 2004-06-22 EP EP09158304.7A patent/EP2100520B1/en not_active Revoked
- 2004-06-22 AT AT04748674T patent/ATE363213T1/de active
- 2004-06-22 ES ES04748674T patent/ES2285484T3/es not_active Expired - Lifetime
- 2004-06-22 NZ NZ552166A patent/NZ552166A/en not_active IP Right Cessation
- 2004-06-22 ES ES07108969T patent/ES2323988T3/es not_active Expired - Lifetime
- 2004-06-22 EP EP04748674A patent/EP1672987B1/en not_active Revoked
- 2004-06-22 UA UAA200613595A patent/UA81875C2/uk unknown
- 2004-06-22 DE DE602004006765T patent/DE602004006765T2/de not_active Expired - Lifetime
- 2004-06-22 CN CN200480043417A patent/CN100589712C/zh not_active Expired - Lifetime
- 2004-06-22 SI SI200431140T patent/SI1815755T1/sl unknown
- 2004-06-22 WO PCT/NL2004/000444 patent/WO2005122790A1/en not_active Ceased
- 2004-06-22 PL PL04748674T patent/PL1672987T3/pl unknown
- 2004-06-22 ES ES09158304T patent/ES2431363T3/es not_active Expired - Lifetime
- 2004-06-22 PT PT91583047T patent/PT2100520E/pt unknown
- 2004-06-22 RU RU2007102085/10A patent/RU2402240C2/ru active
- 2004-06-22 DK DK09158304.7T patent/DK2100520T3/da active
2005
- 2005-06-22 ZA ZA200700138A patent/ZA200700138B/en unknown
2009
- 2009-07-14 CY CY20091100740T patent/CY1109224T1/el unknown
2012
- 2012-08-24 US US13/594,147 patent/US9084433B2/en not_active Expired - Lifetime
2015
- 2015-06-15 US US14/739,850 patent/US10499676B2/en not_active Expired - Lifetime
2019
- 2019-12-07 US US16/706,725 patent/US11076623B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BRPI0418921A (pt)	2007-11-27
ATE363213T1 (de)	2007-06-15
DK1815755T3 (da)	2009-06-02
JP4903695B2 (ja)	2012-03-28
ES2323988T3 (es)	2009-07-28
ES2431363T3 (es)	2013-11-26
NZ552166A (en)	2010-05-28
EP1672987B1 (en)	2007-05-30
PT2100520E (pt)	2013-11-06
US20160073669A1 (en)	2016-03-17
WO2005122790A1 (en)	2005-12-29
US20080064656A1 (en)	2008-03-13
UA81875C2 (uk)	2008-02-11
ZA200700138B (en)	2008-05-28
DE602004006765T2 (de)	2008-01-24
US11076623B2 (en)	2021-08-03
CA2570205C (en)	2012-10-30
RU2402240C2 (ru)	2010-10-27
DE602004020813D1 (de)	2009-06-04
DE602004006765D1 (de)	2007-07-12
US20170042197A9 (en)	2017-02-16
EP1815755A1 (en)	2007-08-08
PL1672987T3 (pl)	2007-10-31
CN1997290A (zh)	2007-07-11
US20130053340A1 (en)	2013-02-28
SI1815755T1 (sl)	2009-08-31
US20200281241A1 (en)	2020-09-10
ES2285484T3 (es)	2007-11-16
US8252769B2 (en)	2012-08-28
EP2100520B1 (en)	2013-07-31
ATE429155T1 (de)	2009-05-15
CY1109224T1 (el)	2014-07-02
EP1672987A1 (en)	2006-06-28
PL1815755T3 (pl)	2009-09-30
PT1672987E (pt)	2007-09-11
CA2570205A1 (en)	2005-12-29
AU2004320743B2 (en)	2010-04-08
AU2004320743A1 (en)	2005-12-29
CN100589712C (zh)	2010-02-17
DK1672987T3 (da)	2007-10-01
EP2100520A3 (en)	2009-11-25
EP1815755B1 (en)	2009-04-22
RU2007102085A (ru)	2008-07-27
US10499676B2 (en)	2019-12-10
EP2100520A2 (en)	2009-09-16
US9084433B2 (en)	2015-07-21
JP2008503568A (ja)	2008-02-07
PT1815755E (pt)	2009-09-03
DK2100520T3 (da)	2013-10-28

Publication	Publication Date	Title
PT1815755E (pt)	2009-09-03	Melhoria da integridade da barreira intestinal
WO2007058538A3 (en)	2008-06-12	Composition with docosapentaenoic acid
NO20065915L (no)	2007-03-22	Forbedring av barriereintegritet i HIV-pasienter
NZ600167A (en)	2014-06-27	Concentrated therapeutic phospholipid compositions
MX338247B (es)	2016-04-07	Metodo de tratamiento de enfermedad de almacenamiento de glucogeno o polisacaridos.
WO2008018043A3 (en)	2008-10-16	Methods of improving bone health and muscle health
WO2011097273A8 (en)	2011-10-20	Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl l-cysteine
SG10201400685SA (en)	2015-01-29	Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia
NZ599067A (en)	2014-04-30	Fatty acid niacin conjugates and their uses
WO2008147562A3 (en)	2009-07-16	Dietary formulations and methods for treatment of inflammation and other disorders
CY1105119T1 (el)	2009-11-04	Χρηση πολυακορεστων λιπαρων οξεων για την πρωτογενη προληψη σοβαρων καρδιαγγειακων επεισοδιων
WO2006078463A3 (en)	2007-05-31	Method for treating cardiovascular disease
WO2009028457A1 (ja)	2009-03-05	非アルコール性脂肪肝炎治療薬
PL2164520T3 (pl)	2020-04-30	Cyklodekstryny do podawania kwasów tłuszczowych w tabletkach
HK1201744A1 (en)	2015-09-11	Composition for improving neuropsychological test battery score
MX2025002883A (es)	2025-04-02	Metodos para proporcionar beneficios para la salud en animales
WO2007021735A3 (en)	2009-04-16	Use of phospholipid arachidonic acids for increasing muscle mass in humans
AR064419A1 (es)	2009-04-01	Composiciones farmaceuticas
WO2010083279A3 (en)	2010-11-18	Methods for treating disorders associated with hyperlipidemia in a mammal
WO2009114090A3 (en)	2009-12-10	Method for inhibiting the build-up of arterial plaque by administering fullerenes
UA115639U (xx)	2017-04-25	Спосіб лікування пацієнтів з коморбідністю неалкогольної жирової хвороби печінки та гіпертонічної хвороби
UA27389U (en)	2007-10-25	Method for treating refractory forms of non-hodgkin lymphoma
AR021830A1 (es)	2002-08-07	Utilizacion de acido docosahexaenoico y acido araquidonico para mejorar el crecimiento de bebes anteriores a termino